Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (665)	8/28/2000 12:17:07 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1475

Thanks, guys. The performance has not been anything special for a biotech during this period, however. But it was a relatively safe investment, given the diversity that Lebowitz et al. had built into the business plan, the size of the markets addressed, and that transplant companies were (and still are) out of favor. Looks like we're working through shares from the recent private placements. We need to get last week's "stem cell" daytraders together with today's "piggie virus" daytraders and see if a light goes off. It will be interesting to see what will happen if and when SCS starts to assume a more public profile.